Filing Flows › AdaptHealth (AHCO) › Capital expenditures
AdaptHealth (AHCO) capital expenditures by quarter
AdaptHealth's capital expenditures were $106M in Q3 2026 (third quarter 2026), -37% from Q2 2026. Over the last 7 quarters it ranged from $88.7M (Q2 2025) to $166M (Q2 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $106M | -37% | +12% |
| Q2 2026 | $166M | +37% | +87% |
| Q1 2026 | $121M | +17% | +27% |
| Q4 2025 | $104M | +10% | — |
| Q3 2025 | $94.2M | +6% | — |
| Q2 2025 | $88.7M | -7% | — |
| Q1 2025 | $95.6M | — | — |
Q3 2026 at a glance
AdaptHealth, Q3 2026: revenue $746M (+11% year over year), operating margin -20.9%, net loss $153M, operating cash flow $157M. The chart follows the revenue to costs, profit and cash.
Questions
What is AdaptHealth's capital expenditures?
AdaptHealth's capital expenditures were $106M in Q3 2026 (third quarter 2026), -37% from Q2 2026.
How has AdaptHealth's capital expenditures changed?
Over the last 7 quarters it ranged from $88.7M (Q2 2025) to $166M (Q2 2026).